Benign tumors with skeletal muscle differentiation are rare and their characterization in the literature is limited. We present a series of twelve pediatric benign tumors with rhabdomyomatous differentiation including seven rhabdomyomatous mesenchymal hamartomas, four fetal rhabdomyomas, and one benign triton tumor, analyzing myogenic markers as well as clinicopathologic and molecular features. A review of the literature was also performed with an emphasis on myogenic marker expression and correlation with molecular features.
Methods and Results
Cases obtained from three tertiary pediatric hospitals were retrospectively reviewed. Eleven of twelve cases expressed myogenin in rare to greater than 15% of cells. Five of nine cases had rare to 70–80% of cells positive for MyoD1. One fetal rhabdomyoma demonstrated homozygous deletions in ZEB2. The benign triton tumor harbored a CTNNB1 mutation. Review of the literature identified 160 pediatric benign tumors with skeletal muscle differentiation of which 9 reported myogenin positivity.
Conclusions
Myogenin and MyoD1 may be variably expressed in benign lesions with skeletal muscle differentiation. Recognition of key morphologic features remains critical to diagnose these lesions and, in rhabdomyoma, to exclude malignancy. Our series expands the knowledge of the relationship between rhabdomyoma and rhabdomyosarcoma (RMS) by identifying a shared molecular alteration in ZEB2.
MazzaJMLinnellEVotavaHJWisoffJHSilverbergNB.Biopsy-proven spontaneous regression of a rhabdomyomatous mesenchymal hamartoma.Pediatr Dermatol. 2015;
32(2):256–262.
3.
FolpeAL.MyoD1 and myogenin expression in human neoplasia: a review and update.Adv Anat Pathol. 2002;
9(3):198–203.
4.
CessnaMHZhouHPerkinsSL, et al.
Are Myogenin and MyoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.Am J Surg Pathol. 2001;
25(9):1150–1157.
5.
KumarSPerlmanEHarrisCARaffeldMTsokosM.Myogenin is a specific marker for rhabdomyosarcoma: an immunohistochemical study in paraffin-embedded tissues.Mod Pathol. 2000;
13(9):988–993.
6.
WangNPMarxJMcNuttMARutledgeJCGownAM.Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round tumors of childhood.Am J Pathol. 1995;
147(6):1799–1810.
7.
EusebiVDamianiSPasquinelliGLorenziniPReuterVERosaiJ.Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases.Am J Surg Pathol. 2000;
24(2):223–230.
8.
MarucciGHadjmohammadiNCenniPRagazziniTEusebiV. [
Malignant glial tumor with skeletal muscle differentiation. Description of a case]. Pathologica. 2000;
92(3):198–203.
9.
FolpeALGrahamRPMartinezASchembri-WismayerDBolandJFritchieKJ.Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.Hum Pathol. 2018;
77:28–34.
10.
ChouguleATaylorMSNardiV, et al.
Spindle and round cell sarcoma with EWSR1-PATZ1 gene fusion. Am J Surg Pathol. 2019;
43(2):220–228.
11.
Loarer F Le, Laffont S, Lesluyes T, et al.Clinicopathologic and molecular features of a series of 41 biphenotypic sinonasal sarcomas expanding their molecular spectrum.Am J Surg Pathol. 2019;
43(6):747–754.
12.
HansenTKatenkampD.Rhabdomyoma of the head and neck: morphology and differential diagnosis.Virchows Arch. 2005;
447(5):849–854.
13.
WanWKSngTYGohHKHwangSG.Foetal rhabdomyoma with fine-needle aspirate cytology correlation. Singapore Med J. 2009;
50(4):e138–e140.
14.
LuDYChangSCookH, et al.
Genital rhabdomyoma of the urethra in an infant girl.Hum Pathol. 2012;
43(4):597–600.
15.
CaiZThomasJAlavaIAakashNSalujaKZhuH.Fetal type rhabdomyoma of the soft palate in an adult patient: report of one case and review of the literature.Head Neck Pathol. 2019;
13(2):182–187.
16.
DaviesBNohPSmaldoneMCRanganathanSDocimoSG.Paratesticular rhabdomyoma in a young adult: case study and review of the literature. J Pediatr Surg. 2007;
42(4):e5–e7.
17.
HettmerSTeotLAVan HummelenP, et al.
Mutations in Hedgehog pathway genes in fetal rhabdomyomas.J Pathol. 2013;
231(1):44–52.
18.
CarterJMHoweBMHawseJRGianniniCSpinnerRJFritchieKJ.CTNNB1 mutations and estrogen receptor expression in neuromuscular choristoma and its associated fibromatosis. Am J Surg Pathol. 2016;
40(10):1368–1374.
19.
WatsonJDepasqualeKGhaderiMZwillenbergS.Nevoid basal cell carcinoma syndrome and fetal rhabdomyoma: a case study. Ear Nose Throat J. 2004;
83(10):716–718.
20.
ThakrarRRobsonCDVargasSOMearaJGRahbarRSmithER.Benign triton tumor: multidisciplinary approach to diagnosis and treatment.Pediatr Dev Pathol.
17(5):400–405.
21.
ColiANovelloMTamburriniGAntonelliMGiangasperoFLauriolaL.Intracranial neuromuscular choristoma: report of a case with literature review.Neuropathology. 2017;
37(4):341–345.
22.
PhanITCourtneyRJMarxDPWilsonDJMansoorANgJD.Proptosis caused by rhabdomyomatous mesenchymal hamartomata occurring in the orbit.Ophthal Plast Reconstr Surg.
32(3):e62–e64.
23.
PremalataCSKumarR V.SaleemKMFathimaLJDasK.Fetal rhabdomyoma of the lower extremity.Pediatr Blood Cancer. 2009;
52(7):881–883.
24.
WeintraubHDavisRTapscottS, et al.
The myoD gene family: nodal point during specification of the muscle cell lineage.Science. 1991;
251(4995):761–766.
25.
ZammitPS.Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis.Semin Cell Dev Biol. 2017;
72:19–32.
26.
YangSZhaoCZhangYLiaoS.Mediastinal fetal rhabdomyoma in nevoid basal cell carcinoma syndrome: a case report and review of the literature.Virchows Arch. 2011;
459(2):235–238.
27.
AaronsonNLTomanJCDLernerMZBaumED.Fetal rhabdomyoma of the tongue in a newborn. Ear Nose Throat J. 2015;
94(7):266–268.
28.
TostarUMalmCJMeis-KindblomJMKindblomLGToftgårdRUndénAB.Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.J Pathol. 2006;
208(1):17–25.
29.
KerbratABeaufrereANeiva-VazC, et al.
Rhabdomyosarcoma and rhabdomyoma associated with nevoid basal cell carcinoma syndrome: local treatment strategy.Pediatr Dermatol. 2018;
35(4):e245–e247.
30.
Bridge JA, Liu J, Weibolt V, et al.Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer. 2000;
27(4):337–344.
31.
ButelTKaranianMPierronG, et al.
Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: a report from the French MMT committee. Cancer Med. 2020;
9(8):2698–2709.
32.
HegartySVSullivanAMO’KeeffeGW.Zeb2: a multifunctional regulator of nervous system development.Prog Neurobiol. 2015;
132:81–95.
33.
RogacMKitanovskiLWritzlK.Co-occurrence of rhabdomyosarcoma and Mowat-Wilson syndrome: is there a connection?Clin Dysmorphol. 2017;
26(3):185–186.
34.
KimHChungJHSungHMKimS.Rhabdomyomatous mesenchymal hamartoma presenting as a midline mass on a chin.Arch Craniofacial Surg. 2017;
18(4):292–295.
35.
SampatKCheesmanESiminasS.Perianal rhabdomyomatous mesenchymal hamartoma.Ann R Coll Surg Engl. 2017;
99(6):e193–e195.
36.
StefankoNSDaviesOMTBeatoMJ, et al.
Hamartomas and midline anomalies in association with infantile hemangiomas, PHACE, and LUMBAR syndromes. Pediatr Dermatol. 2020;37(1):78–85.
37.
Solis-CoriaAVargas-GonzalezRSotelo-AvilaC.Rhabdomyomatous mesenchymal hamartoma presenting as a skin tag in the sternoclavicular area.Pathol Oncol Res. 2007;
13(4):375–378.
38.
Orozco-CovarrubiasLCarrasco-DazaDDiaz-NoriegaALara-MendozaLRuiz-MaldonadoR.Rhabdomyomatous mesenchymal hamartoma: a deep subcutaneous lesion in the sternoclavicular area.Pediatr Dermatol. 2016;
33(1):e36–e37.
LamSGrandhiRWongRHamiltonRGreeneS.Neuromuscular hamartoma of the sciatic nerve: case report and review of the literature.Surg Neurol Int. 2013;
4:8.
41.
Hébert-BlouinMNScheithauerBWAmramiKKDurhamSRSpinnerRJ.Fibromatosis: a potential sequela of neuromuscular choristoma: clinical article.J Neurosurg. 2012;
116(2):399–408.
42.
TeotLASchneiderMThornerAR, et al.
Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion–negative rhabdomyosarcoma: a report from the Children’s Oncology Group.Cancer. 2018;
124(9):1973–1981.
43.
WalshSNHurtMA.Cutaneous fetal rhabdomyoma: a case report and historical review of the literature.Am J Surg Pathol. 2008;
32(3):485–491.
44.
YangSHMcCalmontTHAhnGGYehI. Supraorbital cutaneous fetal rhabdomyoma of intermediate type: a case report. Am J Dermatopathol. 2014;36:e93–e96.
45.
Pérez-AlonsoPSánchez-SimónRContrerasFPatrón-RomeroM.Pathological case of the month. Arch Pediatr Adolesc Med. 2000;
154(12):1265–1266.
46.
CarronJDDarrowDHKaraklaDW.Fetal rhabdomyoma of the posterior cervical triangle. Int J Pediatr Otorhinolaryngol. 2001;
61(1):77–81.
47.
O’CallaghanMGHouseMEbaySBhadeliaR.Rhabdomyoma of the head and neck demonstrated by prenatal magnetic resonance imaging.J Comput Assist Tomogr. 2005;
29(1):130–132.
48.
LeboulangerNPicardARogerGGarabedianEN.Fetal rhabdomyoma of the infratemporal fossa in children.Eur Ann Otorhinolaryngol Head Neck Dis. 2010;
127(1):30–32.
49.
ZhengLTangHChenXYangHYangM.Paratesticular fetal-type rhabdomyoma in a 12-year-old boy: a case report and literature review.Urology. 2013;
82(5):1150–1152.
50.
WhiteLRAgrawalVSuttonLBalbosaAC.Rhabdomyomatous mesenchymal hamartoma of the face causing trigeminal neuralgia.Am J Case Rep. 2015;
16:338–340.
51.
McKinnonELRandAJAngelica SelimMFuchsHEBuckleyAFCummingsTJ.Rhabdomyomatous mesenchymal hamartoma presenting as a sacral skin tag in two neonates with spinal dysraphism.J Cutan Pathol. 2015;
42(10):774–778.
52.
FontecillaNMWeitzNADayCGolasARGrossmanMEReiffelR.Rhabdomyomatous mesenchymal hamartoma presenting as a skin tag in a newborn.JAAD Case Rep. 2016;
2(3):222–223.
53.
SayanADinizGMertMEkinZYKoyluogluG.Rhabdomyomatous mesenchymal hamartoma developed at an unexpected location.Arch Argent Pediatr. 2019;
117(5):E519–E522.
Vijay ShankarKASNischalKCBasavarajHB.Benign triton tumor: a rare entity in head and neck region.Korean J Pathol. 2013;
47(1):74–76.
56.
ParkJE.Long-term natural history of a neuromuscular choristoma of the sciatic nerve: a case report and literature review.Clin Imaging. 2019;
55:18–22.
57.
HemalathaALSanjayMAnooshaKAshokKPShanthaKumari BR.Benign triton tumour of upper lip—a rare neoplasm at an extremely uncommon site. J Clin Diagn Res. 2014;
8(12):FD03.
58.
BroskiSMHoweBMSpinnerRJAmramiKK.Fibromatosis associated with neuromuscular choristoma: evaluation by FDG PET/CT.Clin Nucl Med. 2017;
42(3):e168–e170.
59.
MaldonadoAASpinnerRJCarterJMStoneJJHoweBM.Clinical and magnetic resonance imaging longitudinal follow-up of neuromuscular choristomas. World Neurosurg. 2019;
129:e761–e766.
